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Hydrogen sulfide has recently been found decreased in
chronic kidney disease. Here we determined the effect and
underlying mechanisms of hydrogen sulfide on a rat model
of unilateral ureteral obstruction. Compared with normal rats,
obstructive injury decreased the plasma hydrogen sulfide
level. Cystathionine-b-synthase, a hydrogen sulfide-
producing enzyme, was dramatically reduced in the ureteral
obstructed kidney, but another enzyme cystathionine-c-lyase
was increased. A hydrogen sulfide donor (sodium hydrogen
sulfide) inhibited renal fibrosis by attenuating the production
of collagen, extracellular matrix, and the expression of
a-smooth muscle actin. Meanwhile, the infiltration of
macrophages and the expression of inflammatory cytokines
including interleukin-1b, tumor necrosis factor-a, and
monocyte chemoattractant protein-1 in the kidney were also
decreased. In cultured kidney fibroblasts, a hydrogen sulfide
donor inhibited the cell proliferation by reducing DNA
synthesis and downregulating the expressions of
proliferation-related proteins including proliferating cell
nuclear antigen and c-Myc. Further, the hydrogen sulfide
donor blocked the differentiation of quiescent renal
fibroblasts to myofibroblasts by inhibiting the transforming
growth factor-b1-Smad and mitogen-activated protein kinase
signaling pathways. Thus, low doses of hydrogen sulfide or
its releasing compounds may have therapeutic potentials in
treating chronic kidney disease.
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Tubulointerstitial fibrosis is the final common pathway to
chronic kidney diseases (CKD).1 Pathologically, renal fibrosis
manifests as the formation of myofibloblasts and the
deposition of extracellular matrix proteins in the renal
interstitium.2 The mechanisms of renal fibrosis have not
been fully elucidated and effective drugs are still scarce.
Renin–angiotensin–aldosterone system is one of the main
culprits of renal fibrogenesis, and renin–angiotensin–
aldosterone system inhibitors remain the first-line drugs in
fighting renal fibrosis.3 However, the renin–angiotensin–
aldosterone system inhibitors may deteriorate renal function
and cause hyperpotassemia when serum creatinine rises
above 3mg/dl.4 New antifibrotic agents are therefore needed
to expand therapeutic options and decrease side effects,
which is especially important for azotemia patients.
Hydrogen sulfide (H2S) represents the third gasotrans-
mitter along with nitric oxide and carbon monoxide.5 It is
generated by cystathionine-g-lyase (CSE), cystathionine-b-
synthase (CBS), and 3-mercaptopyruvate sulphurtransferase.
CBS and CSE are enriched in renal proximal tubules and
produce H2S in kidney in a combined way.
6 H2S plays
various physiological and pathological roles in the kidney.
For instance, it exhibits diuretic, natriuretic, and kaliuretic
properties by increasing glomerular filtration rate and
functions as an oxygen sensor in the renal medulla.6,7
Recently, it was reported that plasma H2S level was
decreased in 5/6 nephrectomy rat and uremia patients,8,9
suggesting that uremic toxin of CKD impairs the production
of endogenous H2S.
Notably, the biological functions of H2S in CKD are not
fully understood. Heterozygous cbs / mice with unilateral
nephretomy, an animal model of CKD, developed proteinuria
and collagen deposition, and increased the expressions of
matrix metalloproteinase-2 and -9.10 Emerging evidence also
demonstrates that H2S exhibits antifibrotic effects in the
lung, heart, and liver.11–13 Furthermore, H2S bears some
similarities to the other two gaseous molecules, nitric oxide
and carbon monoxide, both of which protect the kidney from
renal fibrosis.14,15 Taken together, we hypothesize that H2S
may attenuate renal fibrosis.
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In this study, we examined the effect of H2S on unilateral
ureteral obstructive (UUO) animal model and defined its safe
and effective dosage range. Furthermore, we investigated the
roles of H2S in renal fibroblast proliferation and differentia-
tion. The potential mechanisms were also explored.
RESULTS
CBS expression and plasma H2S levels are decreased in the
obstructed kidney
To investigate whether endogenous H2S was involved in the
pathogenesis of renal fibrosis, we examined the expression
and activity of H2S-producing enzymes CBS and CSE, as well
as plasma H2S levels. The CBS expression was nearly
completely ablated by obstructive injury at day 14, whereas
CSE was increased. In contrast, the expressions of CBS and
CSE in the contralateral kidneys were not affected
(Figure 1a–c). Moreover, H2S generation in the obstructed
kidneys was dramatically reduced compared with sham-
operated rats (Figure 1d). Plasma H2S levels were reduced by
B30% in UUO rats compared with the sham counterparts
(27.5±4.3 mmol/l vs. 39.4±6.3 mmol/l, P¼ 0.021, Figure 1e).
Immunohistochemistry staining indicated that CBS was
predominantly expressed in proximal renal tubules. UUO
injury time-dependently reduced CBS expression in the
obstructed kidneys without affecting that in the contralateral
and sham-operated kidneys (Figure 2a and b). In contrast,
CSE was mainly located in renal glomeruli, interstitium, and
interlobular arteries of normal rats. UUO injury markedly
increased the CSE expression in the interstitium of
obstructed kidneys. The CSE expression in the unobstructed
kidneys remained unchanged (Figure 2c and d).
NaHS treatment decreases the renal size, increases the
cortical thickness, and ameliorates renal function of UUO rats
To assess the effect of exogenous H2S supplement on renal
fibrosis, we treated UUO rats with incremental doses of
sodium hydrosulfide (NaHS; 5.6, 56, and 560 mg/kg/day) and
CSE inhibitor (DL-propargylglycine (PAG), 25mg/kg/day)
via intraperitoneal injection once daily for 3 days before and
2 weeks after UUO injury. The renin–angiotensin–aldosterone
system inhibitor enalapril (10mg/kg/day) was also admini-
strated via intragastria as a positive control. Gross appearance
(Figure 2a) and group data (Figure 2b and c) showed that
enalapril and NaHS (56 mg/kg/day) reduced the size of the
kidney and increased the renal cortical thickness in UUO
rats. However, these effects were not observed in the rats
treated with NaHS at a higher dose of 560 mg/kg/day or PAG
(Figure 3). Compared with UUO rats, NaHS (56 mg/kg/day)
decreased serum creatinine levels, whereas PAG increased
serum urea nitrogen concentration. There were no differences
of serum electrolytes among each group (Supplementary
Data and Supplementary Table S1 online).
NaHS attenuates renal tubulointerstitial injury and collagen
deposition in renal interstitium
Hematoxylin and eosin staining results indicated that UUO
rats exhibited dilated renal tubule, epithelial cells atrophy, inter-
stitial expansion, and increased infiltration of inflammatory
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Figure 1 | Unilateral ureteral obstructive (UUO) injury downregulates cystathionine-b-synthase (CBS) expression and decreases
hydrogen sulfide (H2S) level in plasma on day 14 after operation. (a) Representative western blots of CBS and cystathionine-g-lyase (CSE)
proteins in sham and UUO group are shown. Relative levels of (b) CBS and (c) CSE were analyzed by normalizing to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). (d) Kidney H2S production and (e) plasma H2S level in sham and UUO group are shown. Data are
mean±s.e.m., n¼ 4–6, #Po0.05, ##Po0.01, ###Po0.001 versus sham group.
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cells at 14 days after operation. The tubulointerstitial injury
of UUO rats was ameliorated when treated with NaHS
(5.6 and 56 mg/kg/day) and enalapril. NaHS at 560 mg/kg/day
and PAG failed to ameliorate the tubulointerstitial injury
compared with UUO group (Supplementary Data and
Supplementary Figure S1 online).
Masson trichrome staining demonstrated that UUO injury
resulted in a significant accumulation of collagen fibrils (blue
area) compared with the sham group. Enalapril and NaHS
(5.6 and 56 mg/kg/day) attenuated the fibrotic lesions with
less collagen deposited in the renal interstitium. In contrast,
NaHS at 560 mg/kg/day and PAG increased the collagen
production compared with that of the UUO group (Figure 4a
and b).
NaHS inhibits the expression of SMA and fibronectin in the
obstructed kidney
To evaluate whether H2S reduced the production of
myofibroblasts and extracellular matrix, the renal expression
of a-smooth muscle actin (a-SMA) and fibronectin were
detected on day 14 after UUO operation. Immunohisto-
chemistry staining and semiquantitative analysis showed that
enalapril and NaHS (5.6 and 56 mg/kg/day) decreased the
expressions of a-SMA and fibronectin of the UUO rats.
In contrast, NaHS 560 mg/kg/day and PAG increased the
production of these proteins, but statistical difference was not
obtained in the PAG group (Figure 5a–d). These observa-
tions were verified by western blot analysis, in which NaHS,
especially at the dose of 56 mg/kg/day, markedly reduced the
expressions of a-SMA, fibronectin, phospho-Smad3, and
transforming growth factor-b1 (TGF-b1) (Figure 6a–d).
NaHS inhibits inflammation in the kidney after obstructive
injury
The effect of H2S on the infiltration of inflammatory cells in
obstructed kidneys was also determined at 7 days after UUO.
CD68 (a macrophage marker) staining in renal cortex
revealed an increased macrophage infiltration in the renal
interstitium of UUO rats. NaHS (5.6 and 56 mg/kg/day) and
enalapril markedly reduced the number of macrophage in the
interstitium against the UUO group. This effect was
most pronounced in the NaHS (56 mg/kg/d)-treated group.
Compared with the UUO group, NaHS at 560 mg/kg/day
increased the number of macrophage in renal cortex, whereas
PAG tended but failed to significantly increase the CD68-
positive cell number (Figure 7a and b).
To confirm the anti-inflammatory effect of NaHS, the
mRNA levels of interleukin-1b, tumor necrosis factor-a, and
monocyte chemoattractant protein-1 were determined by
quantitative PCR. All these inflammatory molecules were
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Figure 2 | Expression and localization of cystathionine-b-synthase (CBS) and cystathionine-c-lyase (CSE) in rat renal cortex after
unilateral ureteral obstructive (UUO) injury. (a, b) CBS was predominantly expressed in proximal renal tubules. CBS expression in the left
(obstructed) kidneys was reduced at 3 (3d), 7 (7d), and 14 days (14d) after UUO injury, whereas it remained unchanged in the right
(contralateral) kidneys. (c, d) CSE was mainly located in renal glomeruli, interstitium, and interlobular arteries and was markedly increased in the
left (obstructed) kidneys at 3, 7, and 14 days after operation. In contrast, its expression in unobstructed kidneys was not altered. Scale
bar¼ 200mm. Data are mean±s.e.m., n¼ 4, ###Po0.001 versus sham group, **Po0.01 versus UUO 3-day group, þ þ þPo0.001 versus UUO
7-day group.
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Figure 3 | Sodium hydrosulfide (NaHS) treatment decreases the size and increases the cortical thickness of unilateral ureteral
obstructive (UUO) kidney. (a) General appearance of four representative left kidneys of rats subjected to various treatments. UUO rats
received vehicle (saline) treatment. NaHS (5.6, 56, and 560 mg/kg/day) and DL-propargylglycine (PAG; 25mg/kg/day) were intraperitoneally
given once daily 3 days before and continued for 2 weeks after operation, whereas enalapril (10mg/kg/day) was given via intragastria.
(b) Relative lengths of the left kidney calibrated by the right counterpart of the same rat in different groups. (c) Renal cortex thickness in the
mid-portion of left kidney in coronal section. Data are mean±s.e.m. (n¼ 7), ###Po0.001 versus sham group; *Po0.05, ***Po0.001 versus UUO
group.
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increased by UUO injury. NaHS (5.6 and 56 mg/kg/day) and
enalapril suppressed the expression of these cytokines,
whereas NaHS at 560 mg/kg/day and PAG were unable to
exhibit anti-inflammatory effects (Figure 7c).
NaHS suppresses the NRK-49F cell proliferation induced by
fetal bovine serum (FBS)
We further performed an in vitro study to investigate the
antiproliferation effect of H2S on renal fibroblast using NRK-
49F cells. Cells were exposed to various concentrations
(1–500 mmol/l) of NaHS for 30min, followed by stimulation
with 10% FBS for 24 h. Cells with serum-free medium were
set as controls. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide) assay showed the cell number
was significantly increased after incubation with 10% FBS for
24 h (Po0.05, Figure 8a). Preincubation with NaHS (10, 50,
100, and 500 mmol/l) reduced the cell number by 17.6%,
14.8%, 21.4%, and 16.2%, respectively. However, statistical
difference was only reached in 100 mmol/l NaHS group and
the dose-dependent effect was not observed.
Furthermore, we continued to test whether H2S inhibited
the DNA synthesis of renal fibroblast cells using bromodeox-
yuridine (BrdU) incorporation assay. The DNA synthesis
triggered by 10% FBS was significantly decreased by NaHS
(100 mmol/l) before treatment (Figure 8b and c). To delineate
the mechanism beneath the antiproliferation effect of H2S,
the expression of proliferation-related genes, including
proliferating cell nuclear antigen (PCNA) and c-Myc, was also
assessed. Preincubation with 100 mmol/l NaHS consistently
attenuated the expressions of PCNA and c-Myc proteins
induced by 10% FBS stimulation for 24 h (Figure 8d–f).
NaHS blocks the differentiation of quiescent renal fibroblasts
to myofibroblasts
Because TGF-b1 is the most potent cytokine controlling the
phenotype switch from renal fibroblasts to myofibroblasts,
we investigated the effect of H2S on renal fibroblast activation
induced by TGF-b1. Reverse transcription–PCR demon-
strated that NaHS pretreatment inhibited the mRNA
expressions of collagen I, a-SMA, and fibronectin induced
by TGF-b1 (Figure 9a–d). Western blot analysis also revealed
a significant elevation of a-SMA and fibronectin expression
in NRK-49F cells after TGF-b1 stimulation. These effects
were essentially abolished by NaHS (Figure 9e and f).
a
b α-SMA
Fibronectin
cSham UUO Enalapril + UUO NaHS (5.6 μg/kg/day) + UUO
NaHS (56 μg/kg/day) + UUO NaHS (560 μg/kg/day) + UUO PAG + UUO
Sham UUO Enalapril + UUO NaHS (5.6 μg/kg/day) + UUO
NaHS (56 μg/kg/day) + UUO NaHS (560 μg/kg/day) + UUO PAG + UUO
d
10
###
***
***
*
*
8
6
4
2
0
Sh
am UU
O
En
ala
pri
l +
 UU
O
Na
HS
 (5.
6 μ
g/k
g/d
ay)
 + U
UO
Na
HS
 (56
 μg
/kg
/da
y) +
 UU
O
Na
HS
 (56
0 μ
g/k
g/d
ay)
 + U
UO
PA
G +
 UU
O
Fi
br
on
ec
tin
-p
os
itiv
e
 a
re
a
 (%
)
###
***
***
**
*
15
10
5
0
Sh
am UU
O
En
ala
pri
l +
 UU
O
Na
HS
 (5.
6 μ
g/k
g/d
ay)
 + U
UO
Na
HS
 (56
 μg
/kg
/da
y) +
 UU
O
Na
HS
 (56
0 μ
g/k
g/d
ay)
 + U
UO
PA
G +
 UU
O
α
-
SM
A-
po
sit
ive
 a
re
a
 (%
)
Figure 5 | Sodium hydrosulfide (NaHS) inhibits the expressions of fibronectin and a-smooth muscle actin (a-SMA) in the obstructed
kidneys at 14 days after unilateral ureteral obstructive (UUO) operation. Representative immunohistochemistry images for the expression
of (a) fibronectin and (b) a-SMA, and semiquantitative analysis of these two proteins are presented. PAG, DL-propargylglycine. Scale bar
¼ 200 mm. Data are mean±s.e.m. of 10 non-overlapping fields from four animals per group, ###Po0.001 versus sham group; *Po0.05,
**Po0.01, ***Po0.001 versus UUO group.
1322 Kidney International (2014) 85, 1318–1329
bas i c resea rch K Song et al.: Effect of H2S on UUO
NaHS abolishes the phosphorylation of the MAPKs and
Smad3
TGF-b1-Smad and mitogen-activated protein kinase
(MAPK) pathways are two critical signaling mechanisms
implicated in renal fibrosis. We therefore examined the effects
of H2S on the TGF-b1-induced phosphorylation of Smad3,
p38, c-Jun N-terminal kinase (JNK), and extracellular
signal–regulated kinase (ERK) with western blot analysis.
TGF-b1 (2 ng/ml) triggered the phosphorylation of these
proteins with distinct patterns. The phosphorylation of p38
peaked at 0.5 h after TGF-b1 stimulation, quicker than that of
the other molecules. Specifically, phosphorylation of ERK
and JNK peaked at 2 h after TGF-b1 exposure whereas Smad3
at 1 h (data not shown). Pretreatment with 100 mmol/l NaHS
abolished the increase of Smad3 and MAPKs phosphoryla-
tion induced by TGF-b1 stimulation (Figure 10).
DISCUSSION
UUO is a well-established animal model featured by
progressive renal fibrosis and tubulointerstitial injury. In this
study, we demonstrated that exogenous H2S suppressed
collagen and extracellular matrix deposition in the UUO rats.
We also identified that H2S blocked renal fibrosis via multiple
mechanisms. It inhibited renal fibroblast proliferation by
reducing DNA synthesis and downregulating the expressions
of proliferation-related proteins. H2S also blocked cell
differentiation by suppressing the TGF-b1-Smad and MAPK
signal pathways. Besides, H2S inhibited the inflammatory
process induced by UUO injury.
The association of H2S and renal fibrosis is not well
defined. Our study demonstrated that plasma H2S levels and
endogenous H2S production in the obstructed kidneys were
decreased in UUO rats. As UUO model is devoid of any
exogenous toxin, or a ‘uremic’ environment,16 our finding
implies that renal fibrosis per se could reduce the H2S
generation. Our study further demonstrated that CBS was
predominantly expressed in renal tubules whereas CSE was
mainly located in glomeruli and interstitial vessels, consistent
with a recent report.17 UUO injury markedly decreased the
expression of CBS but increased that of CSE in the renal
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Figure 6 | Sodium hydrosulfide (NaHS) downregulates the expression of fibrosis-associated and signaling molecules in the obstructed
kidneys at 7 days after unilateral ureteral obstructive (UUO) operation. Whole kidney tissue lysates were immunoblotted with antibody
against (a) a-smooth muscle actin (a-SMA), (b) fibronectin, (c) transforming growth factor-b1 (TGF-b1), and (d) phospho-Smad3 in each group
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interstitium. This finding is consistent with previous studies
that CBS is more predisposed to decrease in kidney disease
compared with CSE. For instance, CBS was decreased 6 weeks
earlier than CSE in rat remnant kidney.8 In renal
ischemic–reperfusion rats, CBS was reduced as earlier as 6 h
after reperfusion,18 whereas CSE was increased by prolonged
reperfusion for 24 h.19 Hence, the increase of CSE observed in
this study could be explained as a ‘compensatory mechanism’
to maintain the H2S level. As CSE is abundant in glomeruli,
H2S may also be beneficial for glomerular diseases. A recent
study by Lee et al.20 confirms this notion that H2S is able to
protect the renal glomerular epithelial cells from high
glucose–induced injury, indicating the reduction of H2S is
involved in diabetic nephropathy.
As the endogenous H2S production was reduced by UUO
injury, it is logical to hypothesize that exogenous H2S
supplementation could relieve renal fibrosis. We observed
that the antifibrotic effect of NaHS started at 5.6 mg/kg/day,
peaked at 56 mg/kg/day, but was reversed at 560 mg/kg/day.
Our results were in line with a prior study in which the most
effective NaHS dose on cardiac ischemia–reperfusion injury
was 56 mg/kg/day.21 Moreover, low doses of NaHS (78 and
392 mg/kg/day body weight, twice daily) also reduced
pulmonary fibrosis induced by bleomycin.11 Previous
studies demonstrated that H2S level in vertebrate blood
varied from 10–300 mmol/l by the methylene blue assay.22,23
Using a sensitive fluorescent probe,24 we found the plasma
H2S level in normal rat was B30–40 mmol/l, whereas its
counterpart in the UUO rat was 20–30 mmol/l. Nevertheless,
the precise determination of H2S in biological samples is still
controversial. More sensitive techniques such as monobro-
mobimane-based assay and quantum dot/nanoparticle
methods recently indicated that blood and tissue H2S
concentrations were as low as 0.15–0.9 mmol/l.25,26 These
findings may justify the application of H2S at relatively low
doses in treating renal fibrosis.
Although H2S is beneficial in most animal models of renal
diseases, endogenous H2S has been reported detrimental in
acute kidney injury caused by nephrotoxic drugs. For
instance, the CSE inhibitor PAG (50mg/kg/day) reduced
the kidney damage of Wistar rats induced by cisplatin and
adriamycin.27,28 This is inconsistent with our data in which
PAG was unable to relieve renal fibrosis. In fact, 50mg/kg/day
PAG treatment resulted in a great weight loss of normal
Sprague–Dawley rats in our study (data not shown), and the
dose had to be lowered to 25mg/kg/day. Such conflicting
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Figure 7 | Sodium hydrosulfide (NaHS) inhibits the macrophage infiltration in the obstructed kidneys at 7 days after unilateral ureteral
obstructive (UUO) operation. (a) Representative pictures of kidney sections stained with anti-CD68. A total of 10 fields from 4 animals
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aspects of H2S implicate that diverse mechanisms of H2S may
exist in different animal models and species. Despite this,
caution must be taken in interpreting the effect of PAG
because of its nonselective inhibitory action of CSE. It has
been reported that D-amino acid oxidase and L-alanine
transaminase can also be inhibited by PAG.29,30 Possibilities
cannot be ruled out that the protective effect of PAG in renal
disease may be mediated by inactivating other enzymes rather
than CSE.
Fibroblast proliferation and phenotypic transition to
myofibroblast are two major cellular events of renal fibrosis.31
FBS contains numerous growth factors that promote the
proliferation and differentiation in many types of cells. The
effect of H2S on cell proliferation seems to be cell specific.
Some studies reported that H2S promoted the proliferation
in rat intestinal epithelial cells and human colon cancer
cells, whereas others demonstrated that it inhibited the
proliferation of lung fibroblasts and pancreatic stellate
cells.32,33 Our data revealed that NaHS at 100 mmol/l not
only decreased the cell number, but also inhibited the DNA
synthesis stimulated by FBS. These findings were further
verified by the fact that NaHS downregulated the expressions
of proliferation-related genes including PCNA and c-Myc.
Previous studies also indicated that H2S induced DNA
damage in many cell types.34 The proliferation and cell cycle
proteins such as p53, p21, and cyclin D1 were downregulated
by H2S.
35,36
Numerous cytokines and growth factors such as TGF-b1,
platelet-derived growth factor, tissue plasminogen activator,
and plasminogen activator inhibitor-1 are involved in the
phenotypic switch of fibroblast to myofibroblast.37–40
Microarray analysis in an intestinal cell line suggests that
TGF-b1 and MAPK kinases are regulated by H2S.41 Our
results showed that NaHS at 100 mmol/l suppressed mRNA
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and protein expressions of a-SMA and fibronectin induced
by TGF-b1. In addition, H2S attenuated the phosphorylation
of Smad3, a major pathway in the signal transduction of
TGF-b1. These data suggested that H2S inhibited the fibro-
blast differentiation and extracellular matrix production
partially by blocking the TGF-b1-Smad signaling. In addi-
tion to Smad-dependent pathway, MAPK kinases also engage
in the effect of TGF-b1. ERK, p38, and JNK have been found
to be activated in UUO model and regulate the proliferation,
migration, and differentiation of fibroblast.42 Our data
indicated that H2S reversed the phosphorylation increase of
p38, ERK, and JNK stimulated by TGF-b1 in renal interstitial
fibroblasts, implying that the blockade of MAPK kinases
activation may be another mechanism responsible for the
antifibrotic effect of H2S.
Inflammation plays an important role in the priming and
progression of renal fibrosis.43 One of the pathological
features of the UUO rat model is the marked infiltration of
inflammatory cells in the renal interstitium. Substantial data
support the anti-inflammation action of H2S in multiple
organs and systems.44 Our study echoed with these studies
that H2S exhibited an anti-inflammatory property by
reducing macrophage recruitment in renal interstitium. The
inflammatory cytokines such as interleukin-1b, tumor
necrosis factor-a, and monocyte chemoattractant protein-1
were also downregulated by NaHS. MAPKs are involved in
modulating inflammatory processes. For example, JNK has
been identified with the activation of macrophages and
upregulation of proinflammatory mediators, and JNK
inhibition resolves the inflammation.45 Thus, the anti-
inflammatory effect of H2S may be mediated by inhibiting
the MAPK signal pathway.
In summary, this study demonstrates for the first time that
H2S exhibited antifibrotic effects on obstructed nephropathy
and inhibited the proliferation and differentiation of renal
fibroblasts both in vitro and in vivo. The antifibrotic
mechanisms of H2S may involve its anti-inflammation as
well as its blockade on TGF-b1 and MAPK signaling. This
may provide a therapeutic option for renal fibrosis based on
H2S modulation. Low dosage of H2S or its releasing
compounds may have therapeutic potentials in treating CKD.
MATERIALS AND METHODS
Reagents and antibodies
BrdU, PAG, enalapril, and NaHS, as well as antibodies against
PCNA, c-Myc, and BrdU were purchased from Sigma-Aldrich (St
Louis, MO). Recombinant human TGF-b1 and Trizol reagent were
obtained from Invitrogen (Carlsbad, CA). Antibodies against a-
SMA, fibronectin, CBS, and ERK/phosphorylated-ERK were from
Santa Cruz Biotechnology (Santa Cruz, CA). CSE antibody was
purchased from Abnova Chemical (Taiwan, China). Other anti-
bodies unless specified were from Cell Signaling Technology
(Danvers, MA).
Animal surgery and experimental protocols
Male Sprague–Dawley rats (180–200 g) were purchased from
Shanghai Laboratory Animal Commission (Shanghai, China).
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UUO operation was performed as described previously.16 Rats were
randomly divided into the following seven groups: sham, UUO,
UUO with enalapril (10mg/kg/day), UUO with three doses of NaHS
(5.6, 56, and 560 mg/kg/day), and UUO with PAG (25mg/kg/day).
NaHS and PAG were given intraperitoneally once daily 3 days before
surgery and continued for 1 to 2 weeks after operation. Enalapril was
given via intragastria. UUO rats received vehicle (saline) treatment. All
rats were killed at day 7 or 14 days after surgery. The kidneys were
then harvested and plasma was collected accordingly. The
experimental protocols were approved by the Institutional Animal
Care and Use Committee of Soochow University.
Histological analysis and immunohistochemical staining
Kidney samples were fixed in 10% formalin, embedded in paraffin,
and sectioned 4 mm thick. Sections were deparaffined and stained
with Masson trichrome reagents and observed under a light micro-
scope. Renal collagen (blue area) was semiquantitatively measured at
200 magnification in 10 randomly selected fields from 4 animals
using Image Pro-Plus 6.0 software (Bethesda, MD).
For immunohistochemical studies, renal sections were incubated
with antibodies against a-SMA (1:50), fibronectin (1:50), and CD68
(1:50) overnight at 4 1C, and subsequently incubated with corres-
ponding secondary antibodies at room temperature for 1 h.
Peroxidase-Streptavidin-biotin complex (Vector Laboratories,
Burlingame, CA) and diaminobenzidine (Sigma, St Louis, MO)
was used to visualize the proteins. Ten randomly selected fields
(200 magnifications for a-SMA and fibronectin, and 400
magnifications for CD68) were photographed and measured by a
blinded observer using Image Pro-Plus 6.0 software.
Plasma H2S and tissue H2S synthesis measurement
Plasma H2S level was detected using Dansyl azide (DNS-Az), a novel
fluorescent H2S probe (kindly gifted by Professor Binghe Wang,
Georgia State University) as described previously.24 Briefly, DNS-Az
stock solution (2.2mmol/l) was added at 10ml per well in a 96-well
plate, followed by mixing with 100ml plasma. Fluorescence was imme-
diately measured by a fluorescent microplate reader (Tecan M200,
Grodig, Austria) with an excitation at 360nm and emission at 528nm.
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Tissue H2S production measurement was performed as pre-
viously described.46 In brief, the left kidney homogenates were
mixed with 2mmol/l pyridoxal 50-phosphate and 10mmol/l
L-cysteine and 250ml 10% trichloroacetic acid to reach a total volume
of 750ml. After incubation at 37 1C for 30min, 250 ml 1% zinc
acetate was added to trap H2S. Then, 133 ml of 20mmol/l N,N-
dimethyl-p-phenylenedi-amine sulfate in 7.2mol/l HCl and 133ml of
30mmol/l FeCl3 in 1.2mol/l HCl were added. The absorbance of the
solution was determined at 670 nm with a spectrophotometer. The
H2S concentration was calculated against a calibration curve of
NaHS (0.1–100mmol/l).
Cell culture and treatments
Normal rat kidney fibroblasts (NRK-49F) were purchased from
American Type Culture Collection (Manassas, VA) and maintained
in Dulbecco’s modified Eagle’s medium (4.5 g/l glucose) supple-
mented with 10% fetal bovine serum (Gibco, Grand Island, NY). After
preincubation with NaHS at various concentrations (1–500mmol/l)
for 30min, recombinant human TGF-b1 (2 ng/ml) was added for
various periods of time. In the control group, cells were treated with
vehicle only. In proliferation studies, 10% FBS served as stimulators
and the cells were subjected to serum-free medium for 24 h before
experimentation.
Cell proliferation assay
Cell proliferation was assessed by MTT assay and BrdU incorpora-
tion. For the MTT assay, cells (2103/100ml) were seeded in
96-well plate until subconfluence and quiescenced with serum-free
medium for 24 h. Cells were then pretreated with NaHS
(0.1–500 mmol/l) for 30min, followed by incubation with or without
10% FBS for 24 h. MTT (0.5mg/ml) was added at 4 h before
treatment termination. At the end of treatment, medium was
removed and dimethylsulfoxide at 150ml per well was then added.
Absorbance at 490 nm was measured by a microplate reader
(Tecan M200).
For the BrdU incorporation, cells were seeded onto coverslips.
After being pretreated with 100 mmol/l NaHS for 30min, cells were
incubated in medium with or without 10% FBS for 5 h, and pulsated
with BrdU (10mmol/l) for another 5 h. Next, cells were fixed in 4%
paraformadehyde for 20min and DNA was denatured with 2N HCl
at 37 1C for 10min. After blocking, the incorporated BrdU was
detected with a mouse anti-BrdU antibody (1:100, Sigma) at 4 1C
overnight, followed by incubation with Alexa Fluor 555 Donkey
anti-mouse IgG (1:500, Invitrogen) for 1 h. Subsequently, coverslips
were mounted and observed under a fluorescent microscope (AXIO
SCOPE A1; Zeiss, Jena, Germany).
Reverse transcription–PCR and quantitative PCR
Total RNA was extracted with Trizol reagent and reverse
transcription–PCR was performed using an Advantage RT-for-PCR
kit and PCR Master Mix kit (Fermentas, Vilnius, Lithuania)
according to the manufacturer’s instructions. The quantitative PCR
reactions were performed using a real-time SYBR technology and on
ABI Prism 7000 DNA Detection System (Applied Biosystems, Foster,
CA). For each sample, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and 18S RNA was also assayed as an internal control and
final result were normalized to and expressed as ratios of the target
gene/internal controls. The primers used in the PCR reactions are
listed in Supplementary Table S2 online.
Western blot
Given the heterogeneous expression of CBS and CSE in the kidney,
the whole kidney was halved in the middle. One half was used for
histological studies, and the other half was homogenized for western
blotting analysis. Protein samples (20–80 mg) were separated by
8–10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis
gels and transferred onto a polyvinylidene difluoride membrane
(Millipore, Bedford, MA). After blocking in 5% milk/Tris-buffered
saline and Tween-20 buffer, membranes were individually incubated
with antibodies against proteins of interest at an appropriate
dilution (a-SMA (1:1000), fibronectin (1:500), CBS(1:500), CSE
(1:250), ERK/phospho-ERK (1:500), JNK/phospho-JNK (1:500),
P38/phospho-P38 (1:500), phospho-Smad3 (1:500), PCNA (1:1000),
and c-Myc (1:1000)) at 4 1C overnight. Membranes were then washed
and incubated with appropriate horseradish peroxidase–conjugated
secondary antibody for 1 h. Visualization was carried out using an
advanced chemiluminescence kit (GE Healthcare, Buckinghamshire,
UK). The band density was quantified by ImageJ software (Bethesda,
MD). GAPDH or b-actin was used as an internal control.
Statistical analysis
All data are presented as mean±s.e.m. Statistical significance was
determined using Student’s t-test or one-way analysis of variance
followed by a post hoc analysis (Tukey’s test) where applicable. The
significance level was set at Po0.05.
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